Answers are grounded in this paper and cite their sources.
Targeted protein degradation (TPD) is a rapidly evolving field that has expanded the druggable proteome by enabling the selective elimination of proteins across diverse subcellular compartments. Recent mechanistic advances have shed light on protein degradation pathways operating at the Golgi apparatus, creating new opportunities to exploit these processes in chemical biology approaches and eventually for therapeutic intervention. Hijacking Golgi‐associated degradation mechanisms and adapting established TPD modalities will provide a framework to selectively target both Golgi‐resident proteins and numerous secretory and transmembrane proteins that traffic through the Golgi during biosynthesis and maturation. Here, we review recent progress in the field, discuss the unique opportunities and challenges of hijacking Golgi‐associated degradation strategies, and outline future directions for developing the next‐generation of TPD modalities.
No takes yet. Share an insight, caveat, or question.
Murteira et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: